Trial Outcomes & Findings for Clinical Evaluation of the OEC Elite Vascular Mobile Fluoroscopy System (NCT NCT03096483)

NCT ID: NCT03096483

Last Updated: 2019-03-27

Results Overview

Per-subject investigator report for procedure completion using the Investigational Device

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

12 participants

Primary outcome timeframe

2 Months

Results posted on

2019-03-27

Participant Flow

Participant milestones

Participant milestones
Measure
OEC Elite Imaging Arm
Vascular, gastrointestinal (GI), urology or pain management procedures for which use of the OEC Elite system OEC Elite system: Adults undergoing vascular, gastrointestinal (GI), urology or pain management procedures
Overall Study
STARTED
12
Overall Study
COMPLETED
11
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Reasons for withdrawal
Measure
OEC Elite Imaging Arm
Vascular, gastrointestinal (GI), urology or pain management procedures for which use of the OEC Elite system OEC Elite system: Adults undergoing vascular, gastrointestinal (GI), urology or pain management procedures
Overall Study
Withdrawal by site
1

Baseline Characteristics

Clinical Evaluation of the OEC Elite Vascular Mobile Fluoroscopy System

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
OEC Elite Imaging Arm
n=12 Participants
Vascular, gastrointestinal (GI), urology or pain management procedures for which use of the OEC Elite system OEC Elite system: Adults undergoing vascular, gastrointestinal (GI), urology or pain management procedures
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
n=5 Participants
Age, Categorical
>=65 years
10 Participants
n=5 Participants
Sex: Female, Male
Female
2 Participants
n=5 Participants
Sex: Female, Male
Male
10 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 2 Months

Population: Excludes 1 (one) withdrawn subject because subject was withdrawn prior to study procedures using mobile fluoroscopy.

Per-subject investigator report for procedure completion using the Investigational Device

Outcome measures

Outcome measures
Measure
OEC Elite Imaging Arm
n=11 Participants
Vascular, gastrointestinal (GI), urology or pain management procedures for which use of the OEC Elite system OEC Elite system: Adults undergoing vascular, gastrointestinal (GI), urology or pain management procedures
Imaging Guidance Adequacy Assessed by Number of Questionnaires
11 Image Guidance Adequacy Questionnaire

SECONDARY outcome

Timeframe: 2 months

Population: Excludes 1 (one) withdrawn subject because subject was withdrawn prior to study procedures using mobile fluoroscopy.

The total number of per subject survey completion reflecting the investigator opinion of procedures completed with the investigational device

Outcome measures

Outcome measures
Measure
OEC Elite Imaging Arm
n=11 Participants
Vascular, gastrointestinal (GI), urology or pain management procedures for which use of the OEC Elite system OEC Elite system: Adults undergoing vascular, gastrointestinal (GI), urology or pain management procedures
Number of Investigator Procedure Surveys Assessed by Survey Questionnaire
11 Procedure Survey Questionnaire

Adverse Events

OEC Elite Imaging Arm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Beth Heckel

GE Healthcare

Phone: 2623127269

Results disclosure agreements

  • Principal investigator is a sponsor employee The results of this study may not be used in future publications.
  • Publication restrictions are in place

Restriction type: OTHER